Description
POSITRON EMISSION TOMOGRAPHY (PET) RADIOPHARMACEUTICALS - ADD 52.222-90 PET - ADD 52.222-90 AND CHANGE UPS
Base award description: POSITRON EMISSION TOMOGRAPHY (PET) RADIOPHARMACEUTICALS
Modification chain · 7 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-10-01+$240,500= $240,500
- Mod P000012025-09-03+$0= $240,500
- Mod P000022025-09-12+$0= $240,500
- Mod P000032025-10-01+$240,500= $481,000
- Mod P000042025-12-08+$0= $481,000
- Mod P000052026-01-26-$43,450= $437,550
- Mod P000062026-06-16+$0= $437,550
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-10-01 | +$240,500 | $240,500 | POSITRON EMISSION TOMOGRAPHY (PET) RADIOPHARMACEUTICALS |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2025-09-03 | +$0 | $240,500 | POSITRON EMISSION TOMOGRAPHY (PET) RADIOPHARMACEUTICALS - ADD VAAR 852.222-71 |
| Mod P00002· EXERCISE AN OPTION | 2025-09-12 | +$0 | $240,500 | POSITRON EMISSION TOMOGRAPHY (PET) RADIOPHARMACEUTICALS - EXERCISE OY1 |
| Mod P00003· FUNDING ONLY ACTION | 2025-10-01 | +$240,500 | $481,000 | POSITRON EMISSION TOMOGRAPHY (PET) RADIOPHARMACEUTICALS - FUND OY1 |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-12-08 | +$0 | $481,000 | POSITRON EMISSION TOMOGRAPHY (PET) RADIOPHARMACEUTICALS - NEW/ADDITIONAL DELIVERY ADDRESS |
| Mod P00005· FUNDING ONLY ACTION | 2026-01-26 | −$43,450 | $437,550 | POSITRON EMISSION TOMOGRAPHY (PET) RADIOPHARMACEUTICALS - DE-OBLIGATE EXCESS FUNDS, BASE POP |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2026-06-16 | +$0 | $437,550 | POSITRON EMISSION TOMOGRAPHY (PET) RADIOPHARMACEUTICALS - ADD 52.222-90 PET - ADD 52.222-90 AND C… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JV1AHJHGUGG3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0392 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $357,066 | FY2026 |
| 36C25526N0245 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $1,172,834 | FY2026 |
| 36C24226N0463 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $624,017 | FY2026 |
| 36C24226N0388 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $830,796 | FY2026 |
| 36C24226D0040 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C25026P0310 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $347,000 | FY2026 |
Other recipients under 6505 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25726N0367 | ISORX TEXAS LTD | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $53,945 | FY2026 |
| 36C25726N0407 | CARDINAL HEALTH 414, LLC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $1,400,000 | FY2026 |
| 36C25726P0476 | PETNET SOLUTIONS, INC. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $40,573 | FY2026 |
| 36C25726P0423 | PANHANDLE NUCLEAR RX, LTD. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $325,038 | FY2026 |
| 36C25726N0316 | PROGENICS PHARMACEUTICALS INC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $721,744 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25725P0020_3600_-NONE-_-NONE- · retrieved 2026-09-26.